LATEST NEWS

Category Archives: Company

Forendo selected one of the most promising start-up companies in Finland

Forendo Pharma was selected as one of 20 most promising start-up companies in Finland, by Talouselämä, a highly respected finance magazine in Finland. Talouselämä is the only finance magazine published weekly in Finland and also the largest of its kind within the Nordic market. The selection of the most promising start-up companies was based on […]

Meet us in San Francisco during Biotech Showcase 2016

Forendo Pharma will be in San Francisco, California, for meetings with partners during Biotech Showcase and JP Morgan conference, from January 11th to 13th 2016. Biotech Showcase is the leading investor conference for mid-small cap and private biotech and life science companies. Our company presentation will be on Monday, January 11th, at 3:30 pm. Please contact […]

“Growth in Sight” prize awarded to Forendo Pharma

Entrepreneurial Spirit of Turku awards were shared in three categories in Creative Business Camp. Forendo was awarded by “Growth in Sight” prize. http://www.turkusciencepark.com/fi/spark-uutiset/1322/forendo-pharma-mariachi-ja-foodduck-palkittiin-yrittajyyden-yossa/

Press Release: Successful closing of a new investment round.

Forendo Pharma closes EUR 12 million Series A financing round to develop a novel targeted therapy for endometriosis Turku, Finland, October 22nd, 2014. Forendo Pharma today announced the successful closing of a EUR 12 million new investment round. Novartis Venture Fund and MS Ventures will participate in the financing round, alongside the current major shareholders […]

Press Release: Fispemifene US development and commercialization rights licensed to Apricus Biosciences Inc.

Forendo Pharma announces the US licensing of fispemifene to Apricus Biosciences targeting urological conditions in men Turku, Finland, October 20th, 2014. Forendo Pharma Oy announced today that it has entered into a definitive agreement to out-license the US development and commercialization rights for fispemifene to Apricus Biosciences Inc. Fispemifene is a selective estrogen modulator (SERM), […]

Press release

Forendo Pharma: a new drug development company started in Turku with focus on endometriosis and male low testosterone Turku June 25th, 2013. Forendo Pharma OY has announced today that it has closed its first investment round with the leading Nordic start-up investors Karolinska Development AB, Novo Seeds and Finnvera.  The tranched funding commitments together with […]